PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer

作者：N. Zhang, Yanping Gao, Zihang Zeng, Yanyan Luo, Xupin Jiang, J Zhang, Jing Li, Jing Zhang, Yan Gong, Conghua Xie · 发表于：Clinical & Translational Oncology · 年份：2021 · DOI：10.1007/s12094-021-02591-z · 被引用次数：32 · 研究领域：PARP inhibition in cancer therapy、interferon and immune responses、Cancer Immunotherapy and Biomarkers